MacroGenics
Ezio Bonvini is currently the Chief Scientific Officer at MacroGenics, Inc. Prior to that, Bonvini worked at the FDA for nearly two decades, holding various titles including Acting Deputy Director in the Division of Monoclonal Antibodies. Before joining the FDA, Bonvini was a Research Fellow at the National Cancer Institute. Bonvini holds a Specialty in Clinical Hematology and a Doctor of Medicine degree from the University of Genoa.
MacroGenics
1 followers
MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company devel...